Vanguard Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$370M Sell
4,953,332
-146,289
-3% -$10.9M 0.01% 1202
2025
Q1
$324M Sell
5,099,621
-79,767
-2% -$5.07M 0.01% 1234
2024
Q4
$404M Buy
5,179,388
+10,119
+0.2% +$790K 0.01% 1168
2024
Q3
$416M Buy
5,169,269
+28,567
+0.6% +$2.3M 0.01% 1144
2024
Q2
$425M Sell
5,140,702
-256,628
-5% -$21.2M 0.01% 1071
2024
Q1
$461M Sell
5,397,330
-8,979
-0.2% -$766K 0.01% 1043
2023
Q4
$462M Buy
5,406,309
+25,451
+0.5% +$2.18M 0.01% 1015
2023
Q3
$482M Buy
5,380,858
+27,146
+0.5% +$2.43M 0.01% 914
2023
Q2
$456M Buy
5,353,712
+28,725
+0.5% +$2.45M 0.01% 979
2023
Q1
$441M Buy
5,324,987
+82,151
+2% +$6.8M 0.01% 978
2022
Q4
$412M Buy
5,242,836
+47,641
+0.9% +$3.75M 0.01% 989
2022
Q3
$385M Buy
5,195,195
+173,113
+3% +$12.8M 0.01% 983
2022
Q2
$327M Buy
5,022,082
+112,186
+2% +$7.31M 0.01% 1123
2022
Q1
$310M Buy
4,909,896
+28,960
+0.6% +$1.83M 0.01% 1276
2021
Q4
$259M Sell
4,880,936
-6,542
-0.1% -$347K 0.01% 1444
2021
Q3
$345M Sell
4,887,478
-203
-0% -$14.3K 0.01% 1225
2021
Q2
$326M Buy
4,887,681
+4,068
+0.1% +$271K 0.01% 1286
2021
Q1
$542M Buy
4,883,613
+31,331
+0.6% +$3.48M 0.01% 908
2020
Q4
$576M Sell
4,852,282
-12,552
-0.3% -$1.49M 0.02% 804
2020
Q3
$424M Sell
4,864,834
-436,179
-8% -$38.1M 0.01% 844
2020
Q2
$475M Sell
5,301,013
-222,475
-4% -$19.9M 0.02% 789
2020
Q1
$550M Buy
5,523,488
+292,293
+6% +$29.1M 0.02% 641
2019
Q4
$601M Sell
5,231,195
-17,397
-0.3% -$2M 0.02% 741
2019
Q3
$662M Sell
5,248,592
-347,740
-6% -$43.9M 0.02% 667
2019
Q2
$673M Sell
5,596,332
-39,200
-0.7% -$4.72M 0.03% 667
2019
Q1
$493M Buy
5,635,532
+15,535
+0.3% +$1.36M 0.02% 791
2018
Q4
$562M Buy
5,619,997
+290
+0% +$29K 0.03% 656
2018
Q3
$644M Buy
5,619,707
+107,357
+2% +$12.3M 0.03% 672
2018
Q2
$494M Sell
5,512,350
-134,810
-2% -$12.1M 0.02% 781
2018
Q1
$413M Buy
5,647,160
+630,465
+13% +$46.1M 0.02% 844
2017
Q4
$291M Buy
5,016,695
+131,433
+3% +$7.63M 0.01% 1038
2017
Q3
$219M Buy
4,885,262
+142,218
+3% +$6.38M 0.01% 1212
2017
Q2
$187M Buy
4,743,044
+48,719
+1% +$1.92M 0.01% 1271
2017
Q1
$190M Buy
4,694,325
+332,087
+8% +$13.5M 0.01% 1254
2016
Q4
$175M Buy
4,362,238
+167,795
+4% +$6.75M 0.01% 1260
2016
Q3
$152M Buy
4,194,443
+157,352
+4% +$5.7M 0.01% 1289
2016
Q2
$117M Buy
4,037,091
+70,299
+2% +$2.04M 0.01% 1411
2016
Q1
$139M Buy
3,966,792
+129,864
+3% +$4.54M 0.01% 1245
2015
Q4
$124M Buy
3,836,928
+64,249
+2% +$2.07M 0.01% 1316
2015
Q3
$122M Buy
3,772,679
+12,531
+0.3% +$405K 0.01% 1301
2015
Q2
$156M Buy
3,760,148
+110,618
+3% +$4.58M 0.01% 1231
2015
Q1
$164M Buy
3,649,530
+169,798
+5% +$7.63M 0.01% 1152
2014
Q4
$130M Buy
3,479,732
+17,823
+0.5% +$667K 0.01% 1236
2014
Q3
$121M Sell
3,461,909
-3,745
-0.1% -$131K 0.01% 1225
2014
Q2
$122M Sell
3,465,654
-72,763
-2% -$2.57M 0.01% 1258
2014
Q1
$115M Buy
3,538,417
+138,833
+4% +$4.52M 0.01% 1264
2013
Q4
$143M Buy
3,399,584
+208,295
+7% +$8.78M 0.01% 1084
2013
Q3
$127M Buy
3,191,289
+95,587
+3% +$3.81M 0.01% 1088
2013
Q2
$128M Buy
+3,095,702
New +$128M 0.01% 1005